The [Clinical Trial Material Market] is characterized by a range of product types, with small molecules and biologics currently representing the most significant segments. Small molecules have traditionally dominated clinical trials, but the pipeline is increasingly shifting towards biologics, which now constitute a major portion of late-phase pharmaceutical developments . However,...
Bangla